Report Library
All ReportsOpioids and Chronic Neuropathic Pain Management KOL Interview
December 22, 2016
Biomedtracker interviewed a neurologist based in the United States who currently treats over 1000 patients with chronic neuropathic pain
per year to determine his current treatment practices for indications including fibromyalgia and views on the use of opioids and
abuse-deterrent opioids.
Excerpts from this interview are also included in the Pressures and Opportunities in Pain report.
If you are a KOL Insight Subscriber, please access the interview from our KOL Insight portal (Subscribers only).
Biomedtracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.
For our disclosures, please read the Biomedtracker Research Standards.
Excerpts from this interview are also included in the Pressures and Opportunities in Pain report.
If you are a KOL Insight Subscriber, please access the interview from our KOL Insight portal (Subscribers only).
Biomedtracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.
For our disclosures, please read the Biomedtracker Research Standards.
Indications Covered: |
Chronic Pain
Fibromyalgia HIV-Associated Distal Sensory Polyneuropathy (HIV-DSP) Neuropathic Pain |